Company Kelyniam Global, Inc. Other OTC
Equities
KLYG
US4883591004
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Custom Prosthetic Cranial Implants
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | -11.44% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | -11.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ross Bjella
CEO | Chief Executive Officer | - | 18-01-08 |
Director of Finance/CFO | - | 20-01-31 | |
Chief Operating Officer | - | 10-12-31 | |
Desiree Webb
BRD | Director/Board Member | - | - |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 14-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Operating Officer | - | 10-12-31 | |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 14-05-31 |
Ross Bjella
CEO | Chief Executive Officer | - | 18-01-08 |
Desiree Webb
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,923,145 | 16,022,500 ( 53.55 %) | 0 | 53.55 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B | |
+26.14% | 31.88B |